SWOT Analysis for Telesis Bio Inc

Price crossing above SMA20 today, and greater than SMA5
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)
Biggest Price Gainers from Open

Companies with growing costs YoY for long term projects
Stocks with Quarter Change % less than Industry
Companies with High Debt
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Companies Increasing Debt as per Annual Report
Declining Revenue every quarter for the past 2 quarters
Stocks Underperforming their Industry Price Change in the Quarter